Related Experiment Videos
A cellular model system for expression studies of coagulation proteins.
Markus Böhl1, Jürgen Böhl, Bernd Schwenzer
1Institute of Biochemistry, Technical University Dresden, Bergstrasse 66, D-01069 Dresden, Germany.
Journal of Pharmacological and Toxicological Methods
|January 18, 2006
Summary
Hep G2 cells serve as a reliable in vitro model for testing novel nucleic acid-based antithrombotic drugs. Antisense oligonucleotides effectively inhibited prothrombin expression at both protein and mRNA levels in these cells.
Area of Science:
- Biotechnology
- Molecular Biology
- Pharmacology
Background:
- Developing new antithrombotic drugs targeting gene expression necessitates robust in vitro models.
- The liver synthesizes most coagulation proteins, making liver-derived cell lines ideal for study.
- Hep G2 hepatoblastoma cells are proposed as a suitable model for evaluating nucleic acid-based coagulation inhibitors.
Purpose of the Study:
- To characterize Hep G2 cells for prothrombin, tissue factor, and factor VIII expression under various culture conditions.
- To establish reliable assays for screening nucleic acid-based antithrombotic agents.
- To validate Hep G2 cells as an in vitro model for assessing antisense oligonucleotide efficacy on coagulation factor gene expression.
Main Methods:
- Hep G2 cells were cultured and analyzed for coagulation factor expression using enzyme-linked immunosorbent assays (ELISAs).
- Cell viability and proliferation were assessed under different culture conditions.
- A multiplex PCR method was developed to simultaneously detect the impact of compounds on two coagulation proteins and a housekeeping gene.
Main Results:
- Cell culture conditions, particularly the presence of collagen, affected Hep G2 cell proliferation and coagulation factor expression patterns.
- Prothrombin expression levels in Hep G2 cells enabled the selection of an optimal time point for antisense oligonucleotide transfection.
- Prothrombin-specific antisense oligonucleotides successfully inhibited prothrombin expression at both the protein and mRNA levels, independent of culture conditions.
Conclusions:
- Hep G2 cells provide a valuable cellular in vitro model for the validation of nucleic acid-based antithrombotic agents.
- The model system effectively demonstrates the antisense mechanism of action on both protein and mRNA levels.
- This approach facilitates the initial screening and validation of novel gene expression-targeting antithrombotic therapies.